When worlds collide: Th17 and Treg cells in cancer and autoimmunity HM Knochelmann, CJ Dwyer, SR Bailey, SM Amaya, DM Elston, ... Cellular & molecular immunology 15 (5), 458-469, 2018 | 500 | 2018 |
CAR T cells in solid tumors: blueprints for building effective therapies HM Knochelmann, AS Smith, CJ Dwyer, MM Wyatt, S Mehrotra, ... Frontiers in immunology 9, 1740, 2018 | 202 | 2018 |
Fundamentals of T cell metabolism and strategies to enhance cancer immunotherapy GO Rangel Rivera, HM Knochelmann, CJ Dwyer, AS Smith, MM Wyatt, ... Frontiers in immunology 12, 645242, 2021 | 115 | 2021 |
Fueling cancer immunotherapy with common gamma chain cytokines CJ Dwyer, HM Knochelmann, AS Smith, MM Wyatt, GO Rangel Rivera, ... Frontiers in immunology 10, 263, 2019 | 105 | 2019 |
Impact of PD‐L1 expression and human papillomavirus status in anti‐PD1/PDL1 immunotherapy for head and neck squamous cell carcinoma—systematic review and meta‐analysis JJ Patel, DA Levy, SA Nguyen, HM Knochelmann, TA Day Head & neck 42 (4), 774-786, 2020 | 77 | 2020 |
Immune evasion by head and neck cancer: foundations for combination therapy JD Horton, HM Knochelmann, TA Day, CM Paulos, DM Neskey Trends in cancer 5 (4), 208-232, 2019 | 74 | 2019 |
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells CJ Dwyer, DC Arhontoulis, GO Rangel Rivera, HM Knochelmann, ... European journal of immunology 50 (9), 1386-1399, 2020 | 62 | 2020 |
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma HM Knochelmann, JD Horton, S Liu, K Armeson, JM Kaczmar, MM Wyatt, ... Cell Reports Medicine 2 (10), 2021 | 57 | 2021 |
Identification of human CD4+ T cell populations with distinct antitumor activity MH Nelson, HM Knochelmann, SR Bailey, LW Huff, JS Bowers, ... Science advances 6 (27), eaba7443, 2020 | 39 | 2020 |
The evolution of care of cancers of the head and neck region: state of the science in 2020 F Yan, HM Knochelmann, PF Morgan, JM Kaczmar, DM Neskey, ... Cancers 12 (6), 1543, 2020 | 38 | 2020 |
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma S Liu, HM Knochelmann, SH Lomeli, A Hong, M Richardson, Z Yang, ... Cell Reports Medicine 2 (10), 2021 | 35 | 2021 |
IL6 fuels durable memory for Th17 cell–mediated responses to tumors HM Knochelmann, CJ Dwyer, AS Smith, JS Bowers, MM Wyatt, ... Cancer research 80 (18), 3920-3932, 2020 | 31 | 2020 |
The evolving landscape of immunotherapy in solid tumors JM Keilson, HM Knochelmann, CM Paulos, RR Kudchadkar, MC Lowe Journal of surgical oncology 123 (3), 798-806, 2021 | 30 | 2021 |
Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma Y Xiong, DM Neskey, JD Horton, CM Paulos, HM Knochelmann, ... BMC cancer 20, 1-10, 2020 | 30 | 2020 |
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. JD Horton, H Knochelmann, K Armeson, JM Kaczmar, C Paulos, ... Journal of Clinical Oncology 37 (15_suppl), 2574-2574, 2019 | 28 | 2019 |
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell–and CXCR3-dependent manner MB Ware, M Phillips, C McQuinn, MY Zaidi, HM Knochelmann, E Greene, ... JCI insight 8 (8), 2023 | 17 | 2023 |
Progressively enhancing stemness of adoptively transferred T cells with PI3Kδ blockade improves metabolism and antitumor immunity GO Rangel Rivera, CJ Dwyer, HM Knochelmann, AS Smith, BA Aksoy, ... Cancer Research 84 (1), 69-83, 2024 | 14 | 2024 |
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cells MM Wyatt, LW Huff, MH Nelson, LR Neal, AR Medvec, GOR Rivera, ... Molecular Therapy 31 (7), 2120-2131, 2023 | 10 | 2023 |
B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity AS Smith, HM Knochelmann, MM Wyatt, GOR Rivera, AM Rivera-Reyes, ... Journal for ImmunoTherapy of Cancer 10 (1), 2022 | 9 | 2022 |
Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies HM Knochelmann, AM Rivera-Reyes, MM Wyatt, AS Smith, R Chamness, ... Oncoimmunology 10 (1), 1959101, 2021 | 6 | 2021 |